Literature DB >> 35414926

Tongue metastasis originated from esophageal squamous cell carcinoma: A case report.

Seyed Amir Aledavood1, Mahsa Akbari Oryani2, Zohreh Pishevar Feizabad3.   

Abstract

The tongue is a rare site for metastasis. In this report, we present a woman with a history of esophageal squamous cell carcinoma who suffered from two metastatic masses on the left side of her tongue 2 years after completion of definitive chemoradiation. The patient underwent chemotherapy and left hemi-glossectomy.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  aerodigestive malignancy; esophageal cancer; squamous cell carcinoma; tongue metastasis

Year:  2022        PMID: 35414926      PMCID: PMC8980896          DOI: 10.1002/ccr3.5648

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


INTRODUCTION

The esophageal squamous cell carcinoma is known as locally recurrent disease which tends less to metastasize to distant organs compared with its counterpart, that is, adenocarcinoma. However, distant metastases might happen, mostly involving liver, lung, and bone, compromising the survival of patients, significantly. The tongue is a rare site for distant metastasis and only few cases from different origins such as gastrointestinal tract or pulmonary system have been reported. , , Although it is more frequent in patients with disseminated diseases, it could be observed as single site of metastasis or even as the initial presentation of distant metastasis, as well. , In this report, we present a woman with a previous history of esophageal squamous cell carcinoma (ESCC) with final diagnosis of the metastasis to tongue 2 years after definitive chemoradiation.

CASE PRESENTATION

A 54‐year‐old woman with a past history of esophageal squamous cell carcinoma was admitted due to two soft tissue masses on the left side of her tongue. The patient did not mention history of smoking, addiction, or using nasvay. She had no significant past medical history other than her esophageal cancer which was treated by definitive radiation therapy [50 gray/25 fractions during 5 weeks] with concurrent chemotherapy [two cycles of cisplatin (30 mg) and 5‐FU (500 mg) day1–3 every 3 weeks]. After treatment, she was followed up every 4 months and had no specific signs and symptoms till 24 months later when she complained of persistent lumps on the left side of her tongue which were present since last 4 months. Physical examination showed there were two separated painless firm masses on the left side of the tongue without any signs of epithelial and mucosal involvement or ulcer. The incisional biopsy showed nondysplastic epithelium lied over a submucosal carcinomatous neoplasm composed of tumoral cell islands with severe atypia and conspicuous nucleoli along with frequent mitosis, necrosis, and lymphovascular invasion (Figure 1A,B). The primary pathologic diagnosis was poorly differentiated carcinoma which subsequent immunohistochemistry evaluation showed positive staining for CK and P63 and negative staining for CK5/6, EMA, and CEA leading to final diagnosis of metastatic high‐grade squamous cell carcinoma.
FIGURE 1

A (×10) ‐ B (×10): nondysplastic epithelium (*) lied over a submucosal carcinomatous neoplasm composed of tumoral cell islands with severe atypia (___) and conspicuous nucleoli along with frequent mitosis, necrosis, and lymphovascular invasion. C (×40) – D (×10): Total glossectomy following chemotherapy; achieving pathologic complete response following chemotherapy. E (×40): membranous immunostaining of CK20 was seen in tumoral cells F (×40): A strong nuclear p63 immunostaining was seen in tumoral cells

A (×10) ‐ B (×10): nondysplastic epithelium (*) lied over a submucosal carcinomatous neoplasm composed of tumoral cell islands with severe atypia (___) and conspicuous nucleoli along with frequent mitosis, necrosis, and lymphovascular invasion. C (×40) – D (×10): Total glossectomy following chemotherapy; achieving pathologic complete response following chemotherapy. E (×40): membranous immunostaining of CK20 was seen in tumoral cells F (×40): A strong nuclear p63 immunostaining was seen in tumoral cells Esophagogastroduodenoscopy and full‐body computerized tomography (CT) scans with and without intravenous contrast were done. Barium meal revealed smooth narrowing of middle esophagus. However, the endoscopic biopsy of esophageal stricture was normal. Cisplatin (cisplatin, 80 mg/m2/day, day 1) plus 5‐FU (800 mg/m2/day, days 1–5) chemotherapy regimen was commenced and repeated every 3 weeks. After four cycles of treatment, the lingual lesions have shrunk, significantly, depicted on the physical examination. Subsequently, the patient underwent left hemi‐glossectomy, and pathologic examination revealed pseudoepitheliomatous hyperplasia confirming a pathologic complete response (Figure 1C,D). After 1 year of follow‐up, she was disease free.

DISCUSSION

The tongue is an unexpected site of distant metastasis for malignant diseases including esophageal cancers and only few reports are available, mostly originated from the esophageal adenocarcinoma. ,  Therefore, the diagnosis of tongue metastasis as a single site of distant metastasis which is originated from esophageal squamous cell carcinoma is a challenging scenario because of its rarity as the location of metastasis and also possible second primary malignancies of the aerodigestive tract due to potential shared predisposing factors and field cancerization. Histopathologic evaluation might be helpful to distinguish between the primary squamous cell carcinoma of tongue and the metastatic lesions originated from squamous cell carcinoma of other organs. Intact nondysplastic epithelium of tongue is the main characteristic of metastatic lesions as reported in the current case. Shimizu et al. (2021), reported an old man with esophageal cancer who had been diagnosed with a metastasis to the tongue during post esophagectomy adjuvant chemotherapy. In contrast to the patient presented by us, the patient reported by Shimizu et al. suffered from disseminated disease with mediastinal lymph nodes metastases and died 1 year after treatment despite the chemotherapy and radiotherapy. Tunio et al. (2014) reported a case of esophageal adenocarcinoma which had been diagnosed by a tongue metastasis as the initial place of distant metastasis. The patient reported by Tunio et al. died 2 months after surgical resection of tongue mass due to progressive disease, as well. Patients with metastatic esophageal squamous cell carcinoma usually suffer from disseminated disease and single distant metastasis, especially to the tongue, is extremely uncommon. Despite the positron emission tomography–computed tomography (PET‐CT) scan was not performed in our patient, results of the extensive investigations including esophagogastroduodenoscopy and full‐body CT scan did not show neither local nor distant recurrent except the lingual lesion. Because of the rarity of condition, no standard approach for the treatment of patients has been proposed. Considering the morbidity of surgical resection in patients with malignancy of tongue, palliative chemotherapy and or radiotherapy, if there is no overlap with previous radiation plans, are among the best treatment options. ,  The presented patient with solitary distant metastases from esophageal cancer underwent definitive surgery after the preliminary chemotherapy showing a complete response at the pathologic examinations. Definitive surgery can be offered to patients with the isolated recurrence from esophageal cancer without any other evidence of local or distant metastasis and offer a survival benefit for properly selected patients. Beside the conventional chemotherapeutic agent, innovation of newer treatment approaches such as targeted therapy and immunotherapy, , , , introducing newer techniques in delivering the radiotherapy, , and finding newer markers to assess the response to treatments ,  may improve the survival of patients with metastatic esophageal cancer including people with distant metastasis to rare sites.

CONCLUSION

The tongue is a rare site for distant metastasis. However, in patients with a history of malignancy, any persistent lingual mass should be assessed carefully, regardless of its appearance, growth rate, ulceration, and neural symptoms.

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest.

AUTHOR CONTRIBUTIONS

The author listed is the sole author. S.A.A. supervised the case report and contributed to the final version of the manuscript. Z.P.F. contributed to the interpretation of the results and took the lead in writing the manuscript. M.A.O. provided the pathologic images and contributed to the interpretation of them. All authors discussed the results and commented on the manuscript.

ETHICAL APPROVAL

An informed written consent form was obtained from the patient.

CONSENT

An informed written consent form was obtained from the patient.
  19 in total

1.  Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy.

Authors:  Azar Fanipakdel; Mehdi Seilanian Toussi; Faezeh Rezazadeh; Nema Mohamadian Roshan; Seyed Alireza Javadinia
Journal:  J Cell Physiol       Date:  2018-12-19       Impact factor: 6.384

2.  Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases.

Authors:  Yongshun Chen; Xinyu Cheng; Haixia Song; Abraham J Wu; Geoffrey Y Ku; Percy Lee; Marije Slingerland; Kazuo Koyanagi; Shaobo Ke; Hu Qiu; Wei Shi; Yi Gao; Jiamei Chen
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Feasibility of Treatment Planning System in Localizing the COVID-19 Pneumonia Lesions and Evaluation of Volume Indices of Lung Involvement.

Authors:  Ruhollah Ghahramani-Asl; Pejman Porouhan; Mohammad Mehrpouyan; James S Welsh; Edward J Calabrese; Rachna Kapoor; Gaurav Dhawan; Seyed Alireza Javadinia
Journal:  Dose Response       Date:  2020-09-29       Impact factor: 2.658

4.  Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer.

Authors:  Jie Li; Yixue Wen; Zhongzheng Xiang; Huan Du; Lidan Geng; Xiyue Yang; Yu Zhang; Jie Bai; Tangzhi Dai; Gang Feng; Lei Liu; Xiaobo Du
Journal:  Radiother Oncol       Date:  2020-09-25       Impact factor: 6.280

Review 5.  Anti-tumoral effects of low molecular weight heparins: A focus on the treatment of esophageal cancer.

Authors:  Seyed Alireza Javadinia; Arezoo Gholami; Mona Joudi Mashhad; Gordon A Ferns; Soodabeh Shahidsales; Amir Avan; Ali Taghizadeh Kermani
Journal:  J Cell Physiol       Date:  2018-05-09       Impact factor: 6.384

6.  Colorectal Adenocarcinoma Metastasis to the Tongue.

Authors:  Kurren S Gill; Mark A Frattali
Journal:  Case Rep Otolaryngol       Date:  2015-12-02

7.  Tongue metastasis as an initial manifestation of Distant metastasis in Oesophageal Adenocarcinoma.

Authors:  Mutahir A Tunio; Mushabbab AlAsiri; Muhammad Mohsin Fareed; Nagoud Mohamed Omar Ali
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

Review 8.  A case report of tongue metastasis from lung squamous cell carcinoma and literature review.

Authors:  Xiaolong Cheng; Zhenli Hu; Yi-Ping Han; Chong Bai
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

Review 9.  The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature.

Authors:  Dimitrios Schizas; Ioannis I Lazaridis; Demetrios Moris; Aikaterini Mastoraki; Lazaros-Dimitrios Lazaridis; Diamantis I Tsilimigras; Nikolaos Charalampakis; Theodore Liakakos
Journal:  World J Surg Oncol       Date:  2018-03-14       Impact factor: 2.754

Review 10.  Advances in targeted therapy for esophageal cancer.

Authors:  Yan-Ming Yang; Pan Hong; Wen Wen Xu; Qing-Yu He; Bin Li
Journal:  Signal Transduct Target Ther       Date:  2020-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.